I-MAB Banner Image


  • Ticker IMAB
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
I-MAB Logo Image
  • 51-200 Employees
  • Based in Shanghai, China
I-Mab (Nasdaq: IMAB) is a dynamic, global biotech company exclusively focused on discovery, development and soon commercialization of novel or highly differentiated biologics in immuno-oncology. The Company’s mission is to bring transformational medicines to patients around the world through innovation. I-Mab’s innovative pipeline of more than 10 clinical and pre-clinical stage drug candidatesMore is driven by the Company’s Fast-to-PoC (Proof-of-Concept) and Fast-to-Market development strategies through internal R&D and global partnerships. The Company is on track to transitioning from a clinical stage biotech company toward a fully integrated global biopharmaceutical company with cutting-edge R&D capabilities, world-class GMP manufacturing facility and commercial capability. I-Mab has offices in Beijing, Shanghai, Hong Kong and Maryland, United States.

Most Recent Responsibility Report

MOST RECENT 2021 Environmental, Social & Governance Report

I-MAB does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived I-MAB Sustainability Report, I-MAB Corporate Social Responsibility Report, I-MAB CSR Report, I-MAB Corporate Responsibility, I-MAB CR Report, I-MAB Citizenship Report, I-MAB ESG Report, and I-MAB Environmental Report online.
I-MAB Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!